Nine selected hybridoma cell lines that produced monoclonal antibodies against the heat-labile enterotoxin encoded by a plasmid from an Escherichia coli strain of human origin (LTh) were characterized. Hybridomas that produced anti-LTh antibodies with previously unrecognized specificities or reactivities were selected for cloning. Each Only one of the eight anti-LT antibodies had detectable neutralizing activity, and it was specific for LT-A (1). This was unexpected, because hyperimmune antisera prepared * Corresponding author. against either CT or LT neutralized both toxins (3, 6, 9) and all but one of the anti-CT-B monoclonal antibodies tested neutralized CT. Furthermore, some anti-CT-A monoclonal antibodies had neutralizing activity, although their titers were usually low (8, 12, 14) .
antigens: pentameric LTh-B, monomeric LTh-B, LTh-A, and the Al and A2 fragments produced from LTh-A by treatment with trypsin. These monoclonal anti-LTh antibodies and selected anti-LTh and anti-CT monoclonal antibodies described previously were tested for neutralization of LTh, LTp, and CT. Five of the nine new monoclonal antibodies gave detectable cross-reactions with LTp and CT. Four reacted with determinants of LTh that were not present on CT; one of these four did not react with LTp and was specific for a unique epitope of LTh. Three antibodies were specific for LTh-B. All three reacted with pentameric LTh-B, but only one reacted in Western blots with monomeric LTh-B. Six antibodies were specific for LTh-A. Three reacted in Western blots with LTh-A and its Al fragment; the other three did not react in Western blots. All nine of the new monoclonal antibodies neutralized LTh but not CT; the eight that cross-reacted with LTp in binding assays also neutralized LTp. Of four neutralizing anti-CT monoclonal antibodies that bound to LTh, none had significant neutralizing activity against LTh.
Monoclonal antibodies to cholera toxin (CT) and the heat-labile enterotoxin (LT) from Escherichia coli have recently been described; they represent a diverse collection of cross-reacting and unique specificities (1, 8, (12) (13) (14) . The 17 anti-CT antibodies characterized by Holmes and Twiddy were classified into seven different groups based on their binding to the homologous and heterologous enterotoxins or their subunits in solid-phase radioimmunoassays (8) . Three antibodies reacted with CT holotoxin but not with the isolated A subunit (CT-A) or B subunit (CT-B). Eight antibodies were specific for epitopes on CT-A and six were specific for epitopes on CT-B. All of the anti-CT-A antibodies reacted with the intact A subunit or the Al fragment; none was specific for epitopes on the A2 fragment. Of the anti-CT-B antibodies tested, all reacted strongly with the pentameric form of subunit B and some also reacted weakly with the monomeric form of subunit B.
Eight monoclonal antibodies against an LT that is encoded by a plasmid from a clinical isolate of E. coli were isolated and characterized by Belisle et al. (1) . Four were specific for subunit A; this group included one antibody directed against an epitope on the A2 fragment of LT-A. Four reacted with epitopes expressed on the pentameric but not the monomeric form of subunit B. Only two of the eight anti-LT antibodies had specificity patterns detected previously among anti-CT monoclonal antibodies (1, 8) ; six had new patterns of reactivity against the collection of LT and CT test antigens.
Only one of the eight anti-LT antibodies had detectable neutralizing activity, and it was specific for LT-A (1). This was unexpected, because hyperimmune antisera prepared * Corresponding author. against either CT or LT neutralized both toxins (3, 6, 9) and all but one of the anti-CT-B monoclonal antibodies tested neutralized CT. Furthermore, some anti-CT-A monoclonal antibodies had neutralizing activity, although their titers were usually low (8, 12, 14) .
Several predicted specificities were not represented among our collection of monoclonal antibodies against the antigenic variant of LT produced by enterotoxigenic E. coli strains from humans (LTh) (1). These included antibodies specific for LT holotoxin that would not react with LT-A or LT-B, antibodies that would react with monomeric LT-B, and antibodies with strong neutralizing activity against LT. In this study we isolated and characterized additional anti-LT monoclonal antibodies with some of these predicted specificities.
MATERIALS AND METHODS
Bacterial strains and enterotoxins. The bacterial strains, conditions of cultivation, and methods for purification of the enterotoxins and their A and B subunits were the same as those used in our previous studies (1, 8) . The homogeneity of the purified enterotoxins and subunits was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (11) . LTh was purified from sonic lysates of E. coli HE22(pTD2). The to produce 50% of the maximal response with a specified test antigen. Isotyping of the monoclonal antibodies was also performed by solid-phase radioimmunoassay (1) .
Production and isolation of hybridoma cell lines. Preparation of a collection of 87 uncloned hybridoma cell cultures producing monoclonal anti-LTh antibodies was described by Quantitation of antibody in culture supernatants. The concentrations of immunoglobulin G (IgG) monoclonal antibodies were determined by radial immunodiffusion tests with rabbit anti-mouse IgG diluted 1:70 in 1% agarose gels (1) .
The concentration of IgM monoclonal antibodies was determined on commercially obtained radial immunodiffusion plates containing monospecific antibodies to mouse IgM (Meloy Laboratories, Rockville, Md.).
Western blot analyses. The conditions for sample preparation of LTh or trypsin-treated LTh, electrophoresis, and electrophoretic transfer of polypeptides to nitrocellulose paper were the same as those used in our previous study (1) . In that study we found it necessary to raise the pH of the buffer to 9.0 to successfully transfer the pentameric form of LTh-B, hereafter designated LTh-5B. Transfer of the A, A1, A2, and monomeric B peptides was observed at both pH 8.4 and 9.0. In the present study, we found that the efficiency of transfer of monomeric LTh-B was also better at pH 9.0 than at pH 8.4. The nitrocellulose sheets containing the transferred polypeptides were cut into strips, washed, and reacted with hybridoma culture supernatants at a final dilution of 1:10 (1). Protein antibody complexes were detected with peroxidase-conjugated rabbit anti-mouse IgG (16) and 0.0125% diaminobenzidine (2) .
Neutralization tests. Samples containing twofold serial dilutions of hybridoma supernatants were tested for their ability to neutralize 100-pg test doses of LTh, LTp, or CT in Y-1 adrenal cell culture assays (1) . Several cross-reacting anti-CT monoclonal antibodies (8) were also tested for their ability to neutralize LTh and LTp. One unit of neutralizing antitoxin was defined as the smallest amount required to reduce the toxicity of the test dose of the homologous enterotoxin from 4+ to 1 + or 0. RESULTS Our collection of 87 uncloned hybridoma cultures that produced anti-LTh antibodies was screened in neutralization tests and in Western blots to detect antibodies with previously unrecognized specificities or reactivities. On the basis of the results of these preliminary tests, we identified 20 cultures as potential sources of new hybridoma cell lines. From these cultures we were able to isolate nine independently derived, stable cell lines that produced monoclonal antibodies to LTh. The cell lines were expanded, and a pool of at least 250 ml of culture supernatant was prepared from each line. Monoclonal antibodies in these culture supernatants were characterized with respect to their isotypes, binding and neutralization titers for LTh, cross-reactivities in radioimmunoassays with LTh-A, LTh-B, CT, and LTp, and reactivities in Western blots with LTh-A, fragment LTh-Al, monomeric LTh-B, and LTh-5B (Table 1) .
Eight of the newly isolated hybridoma lines produced IgG antibodies, and one produced IgM antibody. All of the monoclonal antibodies contained kappa light chains. Of the IgG antibodies, five were IgGl, one was IgG2a, and two were IgG2b. The concentrations of the monoclonal IgG antibodies in the culture supernatants ranged from 54 to 130 p.g/ml. The concentration of the IgM antibody was 9 ,ug/ml.
Six of the new monoclonal antibodies reacted with epitopes on the LTh-A subunit; they were classified into two different specificity groups. The first group (from clones 2F9, 4B6, and 4E9) was specific for common epitopes that were shared by LTh, LTp, and CT, expressed both on the holotoxin and the isolated LTh-A subunit, and localized by Western blots (Fig. 1) to the A1 fragment derived from LTh-A. The results of quantitative titrations of these antibodies in solid-phase radioimmunoassays with each of the test antigens are shown in Fig. 2A Western blots these antibodies reacted weakly or failed to react with intact LTh-A and did not react with either the LTh-Al or LTh-A2 fragment (Fig. 1) . The behavior of these antibodies in solid-phase radioimmunoassays with each of the test antigens is shown in Fig. 2D to F. The patterns of reactivity of the two IgG2b antibodies from clones 7E6 and 3G2 were similar. The pattern for the IgGl antibody from clone 6C7 was different in that the binding titer for LTh-A was much lower than for LTh. For the three monoclonal antibodies in group 1, the plateaus of the binding curves in assays with LTh-A were higher than the plateaus in assays with LTh holotoxin; the reverse was observed with the antibodies in group 2.
Three of the new monoclonal antibodies (from clones 12G5, 17D3, and 12G6) bound in radioimmunoassays to epitopes of LTh-B that were also expressed on LTh holotoxin (Fig. 3) . None of these antibodies cross-reacted with CT LTp. In Western blots, all three of these antibodies bound to pentameric LTh-B (Fig. 1) . The antibody from clone 12G5 also bound to monomeric LTh-B in Western blots; it is the first anti-LTh monoclonal antibody with this characteristic that we have isolated.
Each of the nine new anti-LTh antibodies isolated in the current study neutralized the biological activity of LTh against cultured Y1 adrenal cells ( Table 1 ). The neutralization titers ranged from 1.6 to 370 U/,ug of monoclonal antibody. Potent neutralizing antibodies were found among both the anti-LTh-B and the anti-LTh-A groups. The monoclonal antibody with the highest neutralizing titer was the anti-LTh-B antibody that was able to bind to monomeric LTh-B in Western blots.
Finally, we tested each of the new anti-LTh monoclonal antibodies for neutralization of the heterologous heat-labile enterotoxins LTp and CT (Table 2) . We also selected the neutralizing anti-CT and anti-LTh monoclonal antibodies from our previous studies that cross-reacted with one or more of the heterologous enterotoxins in radioimmunoassays and tested them for neutralization of the heterologous enterotoxin antigens. None of the neutralizing anti-LTh monoclonal antibodies cross-neutralized CT (less than 0.1 U/,ug of antibody), and none of the neutralizing anti-CT monoclonal antibodies cross-neutralized LTh or LTp. In contrast, all of the anti-LTh antibodies that cross-reacted with LTp in radioimmunoassays also neutralized LTp, and their neutralization titers against LTh and LTp did not differ more than fourfold.
DISCUSSION
In a previous study we prepared a bank of 87 uncloned hybridoma cultures that produced antibodies against LTh (1). Eight hybridoma cell lines were isolated, and six of the eight anti-LTh monoclonal antibodies that they produced had specificities that differed from previously described monoclonal antibodies against CT. However, several specificities that were predicted from classical serological studies (4, 5, 9, 10, 15) and characterization of anti-CT monoclonal antibodies (8, (12) (13) (14) were not represented among our initial set of anti-LTh monoclonal antibodies (1). The present study was therefore designed to isolate new hybridoma cell lines 
